LUNGevity’s board of directors brings to the Foundation decades of experience in corporate management. Our members bring expertise in law, finance, marketing and communications, organizational best practices, and strategic planning to their governance of the organization. In addition, because each has been personally touched by lung cancer, the directors know the urgency associated with lung cancer research. They lend their proficiency, knowledge, and hearts to our endeavor to eradicate lung cancer through research.

Alexander F. Stern

Alexander F. Stern

Chairman

Alex Stern was named President of Lazard Ltd in June 2019.  Alex has served as a Managing Director of Lazard since 2002, and prior to becoming President was Chief Executive Officer of Lazard’s Financial Advisory business since April 2015, Chief Operating Officer of Lazard since November 2008 and Global Head of Strategy since February 2006.


Tom Galli

Tom Galli

Treasurer

Tom Galli is a 14-year lung cancer survivor and a long-term LUNGevity LifeLine mentor. His career in the United States Army and the corporate world spans 45 years and includes a diverse background in civil engineering; tank-automotive system design, development and manufacturing; contracting; program management; and productivity and business process re-engineering consulting.


Nichelle Stigger

Nichelle Stigger

Secretary

Nichelle Stigger is a lung cancer survivor-advocate whose cancer journey began in 2016 when she was diagnosed with a rare form of lung cancer, mucinous adenocarcinoma, found in only 1% of cancer patients.


Lynne Doughtie

Lynne Doughtie

Member

Lynne Doughtie is former U.S. Chairman and Chief Executive Officer of KPMG — one of the world’s leading professional services firms. She also was a member of KPMG’s Global Board and Executive Committee.


Andrea Ferris

Andrea E. Ferris

Member

Andrea is President and CEO of LUNGevity and a member of the Board of Directors. In her role as President and CEO of LUNGevity, Andrea is responsible for setting and executing the strategic direction of the organization and its science programs.


William “BJ” Jones

William “BJ” Jones

Member

BJ Jones is the Chief Commercial Officer, Migraine and Common Disease, at Biohaven Pharmaceuticals, where he is responsible for creating a vertically integrated commercial team from concept to deployment in ten months. 


Jennifer Kashatus

Jennifer Kashatus

Member

Jennifer Kashatus is a partner in the Washington, DC, office of DLA Piper LLP. Jennifer routinely advises companies in all industry sectors on privacy and cybersecurity issues.


Michael Kolodziej, MD

Michael Kolodziej, MD

Member

Michael Kolodziej, MD, serves as Senior Adviser for ADVI Health. He joined ADVI in October 2017. He is a Fellow of the American College of Physicians. He has published and spoken extensively on payment reform, personalized medicine, and practice care delivery transformation in oncology.


Michael Marquis

Michael Marquis

Member

Michael was appointed President of Vogue, a Johnson & Johnson Company, in 2016, and tasked with completing a seamless merger into J&J while plotting a path for Vogue’s growth.


Andre Owens

Andre Owens

Member

Andre’s legal practice, WilmerHale, focuses on securities trading and markets activities. He counsels broker-dealers, securities exchanges, investment advisers, and other clients on a variety of regulatory issues. Andre also provides advice with respect to acquisitions of securities broker-dealers and investment advisers.


Michael Parisi

Michael Parisi

Member

Michael has over 25 years of diverse healthcare industry experience with an intense focus on biotechnology and oncology. Currently he is the CEO of Guidemark Health, a diversified healthcare communications agency with a focus on oncology and rare diseases.


Charles M. Rudin, MD, PhD

Charles Rudin, MD, PhD

Member

“Every week I see patients with this disease. Every week patients suffer relapses. I have watched too many lung cancer patients die. I am trying to change the outcome for patients with this disease.” — Charles M. Rudin, MD, PhD, Chair of the Scientific Advisory Board


Andrew Stern

Andrew Stern

Member

Andrew Stern has spent his entire career focused on early stage company development, financing and operations.


Paul G. Stern

Paul G. Stern

Member

Paul founded Protect Your Lungs after his wife of 43 years, Pat, died of lung cancer.


Robert Winn, MD

Robert Winn, MD

Member

Robert Winn, MD, is director of VCU Massey Cancer Center. In this position, he oversees a cancer center designated by the National Cancer Institute that provides outstanding cancer care, conducts groundbreaking research to discover new treatments for cancer and offers high-quality education, training and community outreach programs.